|
|||||
|
|
Improvement in disease severity and pruritus outcomes with crisaborole ointment, 2%, by baseline atopic dermatitis severity in children and adolescents with mild-to-moderate atopic dermatitis |
|
| Authors: | Lawrence F. Eichenfield MD Gil Yosipovitch MD Linda F. Stein Gold MD Mizuho Kalabis MD PhD Chuanbo Zang PhD Bonnie Vlahos MBA BSN RN Paul Sanders PhD Daniela E. Myers MPH Andrew G. Bushmakin MS Joseph C. Cappelleri PhD Melissa Olivadoti PhD CMMP Amy S. Paller MD MS |
| Affiliation: | 1. Rady Children's Hospital, UC San Diego School of Medicine, San Diego, California, USA;2. Miami Itch Center, Miller School of Medicine, University of Miami, Miami, Florida, USA;3. Henry Ford Health System, Detroit, Michigan, USA;4. Pfizer Inc, Collegeville, Pennsylvania, USA;5. Pfizer R&D UK Ltd, Tadworth, UK;6. Pfizer Inc, Groton, Connecticut, USA;7. Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA |
| Abstract: | |
| Keywords: | atopic dermatitis pruritus therapy-topical |